Objectives: To determine whether skin care practices with iodine-conta
ining disinfectants are putting patients in the neonatal intensive car
e unit al risk for primary hypothyroidism. Cutaneous exposure to povid
one-iodine antiseptic solutions may be a cause of primary hypothyroidi
sm in neonates. Design: Prospective pilot study. Setting: Level III ne
onatal intensive care unit of a university-affiliated hospital. Partic
ipants: Sequential sample of 47 medical and surgical patients admitted
to the neonatal intensive care unit who received cutaneous povidone-i
odine applications in preparation for invasive or surgical procedures.
Methods: Seven to 10 days after iodine exposure, capillary blood samp
les were obtained on filter paper blots for thyroid function testing a
nd urine samples were collected to determine quantitative iodine conce
ntrations. A plasma creatinine level was determined for each subject.
Results: A total of 47 patients were enrolled. The gestational ages of
subjects ranged from 26 to 41 weeks (mean, 33.6 weeks); the male-to-f
emale ratio was 28:19; and the birth weights ranged from 0.7 to 5.1 kg
(mean, 2.42 kg). The thyroxine level ranged from 20 to 187 nmol/L (1.
6 to 14.6 mu g/dL) (mean, 102 nmol/L [7.9 mu g/dL]; reference, greater
than or equal to 90 nmol/L [greater than or equal to 7 mu g/dL]); and
the thyrotropin level ranged from 0.1 to 16.5 mU/L (mean, 6.4 mU/L; r
eference, <20 mU/L). The mean urine iodine concentration was 2798.0 mu
g/dL (reference, <40 mu g/dL), and the mean plasma creatinine level w
as 60 mu mol/L (0.69 mg/dL) (reference, less than or equal to 50 mu mo
l/L [less than or equal to 0.6 mg/dL] for males and less than or equal
to 40 mu mol/L [less than or equal to 0.5 mg/dL] for females). Conclu
sions: There was no documentation of primary hypothyroidism in our sub
jects despite elevated urine iodine levels. While it is still possible
that patients who receive long-term iodine exposure in other settings
leg, cardiac catheterization) are at risk for primary hypothyroidism,
our study suggests that the amount of iodine absorbed through routine
neonatal intensive care unit procedures does not substantially alter
thyroid function during the first 10 days of life, An important confou
nding variable is that seven patients were receiving dopamine hydrochl
oride infusions and four were receiving dexamethasone phosphate at the
time of sample collection. We therefore cannot rule out the possibili
ty that these medications masked a thyrotropin level elevation that wo
uld have occurred in a primary hypothyroid state. We discuss implicati
ons for the interpretation of the results of neonatal thyroid function
tests.